Navigation Links
FDA Approves Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents
Date:11/15/2010

to have ADHD.

The specific etiology of ADHD is unknown, and there is no single diagnostic test for this disorder.  Adequate diagnosis requires the use of medical and special psychological, educational, and social resources, utilizing diagnostic criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR®) or International Classification of Diseases, 10th revision (ICD-10).

Although there is no cure for ADHD, there are accepted treatments that have been demonstrated to improve symptoms.  Standard treatments include educational approaches, psychological therapies which may include behavioral modification, and/or medication.

For further information please contact:SHIRE PLCShire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's Web site: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Cymbalta® for the Management of Chronic Musculoskeletal Pain
2. FDA Approves New Indication for Afinitor
3. FDA Approves Teflaro for Bacterial Infections
4. FDA Approves Latuda to Treat Schizophrenia in Adults
5. FDA Approves Additional Medical Indication for Sprycel
6. FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
7. FDA Approves Pradaxa to Prevent Stroke in People With Atrial Fibrillation
8. FDA Approves Botox to Treat Chronic Migraine
9. FDA Approves Injectable Drug to Treat Opioid-Dependent Patients
10. FDA Approves Pharmaxis ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
11. FDA Approves Combination Contraceptive Containing a Folate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... YORK , May 22, 2015  The ... of Zarxio (filgrastim-sndz) -- the first biosimilar product ... -- points toward growth in the contract ... The mainstream CMO industry is geared to the ... to produce major biopharmaceutical products. The healthcare market ...
(Date:5/22/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ) ... to Prepare Application Dossiers for Oversea Medical device ... report to their offering. The ... market of the most growth potentiality, which is ... and producers to penetrate such market. It is ...
(Date:5/22/2015)... 22, 2015 Richmond Pharmacology ... unit with a worldwide reputation for excellence in ... publications in peer reviewed medical journals. Its officers ... regulators in discussions about rules for transparency and ... (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical research is ...
Breaking Medicine Technology:Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... Corporation plc (Nasdaq: AMRN ) today announced that ... Topics in Therapeutics Roundtable Conference on Wednesday, February 16, 2011. ... 7:45am ET and a company presentation at 9:15am ET. The ... York City. A live audio webcast of the ...
... SAN DIEGO, Feb. 7, 2011 Genoptix, Inc. (Nasdaq: ... has granted early termination of the waiting period under the ... Act") applicable to the cash tender offer by Novartis to ... USD$25.00 per share. The termination of the HSR ...
Cached Medicine Technology:Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference 2FTC Grants Early Termination of Waiting Period Under Hart-Scott-Rodino Act 2
(Date:5/24/2015)... May 24, 2015 Scientists with Cardno ... on air quality compliance issues that may have raised ... Surviving Mesothelioma has just posted an article on the ... , The group found airborne asbestos levels well above ... between 1984 and 2011. , “Asbestos compliance sampling data ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading ... America, Inc. (MTA) has selected IFN as a fiber ... Enterprise Sales Manager, fiber route diversity and network redundancy ... provides MTA with the diverse fiber transport from their ... and voice carriers located at Henry Street in Indianapolis, ...
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 volunteers ... Florida City exactly five years to the day after the ... A large fire tore through the Branches United Methodist Church ... the middle of the night as neighbors, staff and Branches' ... even though it is suspected that the fire began accidentally. ...
(Date:5/23/2015)... May 23, 2015 On Wednesday, May ... “the company has been the target of a sophisticated ... of the company’s ongoing Information Technology (IT) security efforts ... , The most notable attack on health insurers ... Inc., the nation’s second largest health insurer, revealed that ...
(Date:5/23/2015)... WI (PRWEB) May 23, 2015 ... Acceleration at the Sports Medicine and Rehabilitation Center, 557 ... clinic program, Mondays, June 1-July 20, 5:30-6:30 pm. , ... USAT coach, and Laurie Finke, RN, BSN, who will ... exercises, education on nutrition, running mechanics and show selection ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... ... Website Dedicated to Helping Mesothelioma Victims , ... Chicago, Illinois (Vocus) March 10, 2010 -- Mesothelioma is one ... with a great deal of physical, emotional, financial and legal suffering for both the victim ...
... ... next few weeks, thousands of college students across the U.S. will travel ... for abusive drinking. Kathleen Quartaro, a Choose Responsibility volunteer and mother of ... binge drinking during her freshman year, urges parents and students to discuss ...
... ... human body is a self-healing biochemical organism. Unfortunately, modern lifestyles and ... NutriLuxe Solaris tests the body,s biochemical and electrical balance by using ... electrical conductivity, as well as other health factors. Once Solaris identifies ...
... Are ... is the first step toward responsible and conscientious action. , ... (PRWEB) March 11, 2010 -- Like organic food, organic clothing ... Conventional clothing has chemical residues which can be absorbed into your system, especially while ...
... ... address deep-vein thrombosis (DVT) and pulmonary embolism (PE), a growing public health problem estimated ... ... critical recommendations from a national workshop have been released to address deep-vein thrombosis (DVT) ...
... possible long-term effects, experts say, , WEDNESDAY, March 10 ... be an alternative to the widely used statin medications ... and American researchers report. , In the trial, various ... thyroid hormone, were added to statin treatment for 168 ...
Cached Medicine News:Health News:National Asbestos Lawyers of Cooney Conway Launches Mesothelioma Portal 2Health News:National Asbestos Lawyers of Cooney Conway Launches Mesothelioma Portal 3Health News:Mother of Binge Drinking Victim Urges Students and Parents to Discuss Signs of Alcohol Poisoning, Emphasize Peer Responsibility Prior to Spring Break 2Health News:NutriLuxe Offers Personal, At-Home Body Biochemical Balance Test 2Health News:NutriLuxe Offers Personal, At-Home Body Biochemical Balance Test 3Health News:Organic Clothing can be as Crucial to Your Health as Organic Food or Yoga 2Health News:Organic Clothing can be as Crucial to Your Health as Organic Food or Yoga 3Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 2Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 3Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 4Health News:Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism 5Health News:Alternative to Statins Shows Promise 2Health News:Alternative to Statins Shows Promise 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: